Cholesterol gallstone formation in overweight mice establishes that obesity per se is not linked directly to cholelithiasis risk

Journal of Lipid Research

Volumn 43, Issue 7, 2002, Pages 1105-1113

  Bouchard, Guylaine ^a,b   Johnson, Derek ^a   Carver, Tonya ^b   Paigen, Beverly ^b   Carey, Martin C ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b JACKSON LABORATORY   (United States)

Author keywords

Carboxypeptidase E; Cholecystokinin; Cholesterol saturation index; Leptin; Leptin receptor; Monogenic and polygenic obesity genes

Indexed keywords

AGOUTI PROTEIN; CARBOXYPEPTIDASE H; CHOLECYSTOKININ; CHOLESTEROL; CHOLIC ACID; FAT; LEPTIN RECEPTOR; TUBBY RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLELITHIASIS; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DISEASE MODEL; FAT INTAKE; FEMALE; GALLBLADDER; GALLSTONE FORMATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC SUSCEPTIBILITY; HOMEOSTASIS; HORMONE DETERMINATION; INTESTINE MOTILITY; MALE; MONOGENIC DISORDER; MOUSE; MULTIFACTORIAL INHERITANCE; MUSCLE CONTRACTILITY; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SMALL INTESTINE; STONE FORMATION; STRAIN DIFFERENCE; STRAIN IDENTIFICATION;

EID: 0036310490     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M200102-JLR200     Document Type: Article

References (60)

1. Overweight and obesity in the United States: Prevalence and trends, 1960-1994
2. The human obesity gene map: The 1999 update
3. Gallstones
4. Pathogenesis and treatment of gallstones
5. Gallstones
6. The epidemiology of gallbladder disease: Observations in the Framingham study
7. Factors associated with gallstone disease in the MICOL experience
8. Prevalence of gallstone disease in a general population of Okinawa
9. Prevalence rates of gallstone disease in Italy. The Chianciano population study
10. Abnormal processing of the human cholecystokinin receptor gene in association with gallstones and obesity
11. Biliary lipid secretion in cholesterol gallstone disease: The effect of cholecystectomy and obesity
12. Effect of ursodeoxycholic acid on hepatic cholesterol metabolism
13. Gallbladder emptying stimuli in obese and normal-weight subjects
14. Supersaturated bile from obese patients without gallstones supports cholesterol crystal growth but not nucleation
15. Hepatic esterification rate of cholesterol and biliary lipids in human obesity
16. Lith1, a major gene affecting cholesterol gallstone formation among inbred strains of mice
17. Cholic acid aids absorption, biliary secretion, and phase transitions of cholesterol in murine cholelithogenesis
18. Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: Physical-chemistry of gallbladder bile
19. A simple method for the isolation and purification of total lipids from animal tissues
20. Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: Integrated activities of hepatic lipid regulatory enzymes
21. Improved method for determination of high density lipoprotein cholesterol I. Isolation of high density lipoproteins by use of polyethylene glycol 6000
22. Obese, a new mutation in the house mouse
23. Diabetes, a new mutation in the mouse
24. Fat (fat) and tubby (tub): Two autosomal recessive mutations causing obesity syndromes in the mouse
25. Laboratory animals exhibiting obesity and diabetes syndromes
26. Biliary cholesterol hypersecretion in gallstone-susceptible mice is associated with hepatic up-regulation of the high-density lipoprotein receptor SRB1
27. Serum lipids and gallstone disease. A study of self-defense officials in Japan
28. Serum lipids and gallstones: A case-control study
29. Gallstones and plasma lipids in a Danish population
30. Plasma lipids and gallbladder disease
31. The relationship between serum lipids, nucleation time, and biliary lipids in patients with gallstones
32. MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis
33. Etiologic significance of defects in cholesterol, phospholipid, and bile acid metabolism in the liver of patients with intrahepatic calculi
34. The wide spectrum of multidrug resistance 3 deficiency: From neonatal cholestasis to cirrhosis of adulthood
35. Effects of ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene
36. Influence of legume intake on biliary lipids and cholesterol saturation in young Chilean men. Identification of a dietary risk factor for cholesterol gallstone formation in a highly prevalent area
37. Altered processing of procholecystokinin in carboxypeptidase E-deficient fat mice: Differential synthesis in neurons and endocrine cells
38. Carboxypeptidase E activity is deficient in mice with the fat mutation. Effect on peptide processing
39. Purification and characterization of carboxypeptidase D, a novel carboxypeptidase E-like enzyme, from bovine pituitary
40. CCK-A receptor deficient mice have an increased susceptibility to cholesterol gallstones
41. Biological actions of cholecystokinin
42. Influence of small-bowel transit time on dietary cholesterol absorption in human beings
43. Postprandial gallbladder motor function: Refilling and turnover of bile in health and in cholelithiasis
44. Complex genetic control of HDL levels in mice in response to an atherogenic diet. Coordinate regulation of HDL levels and bile acid metabolism
45. Independent and additive effects of central POMC and leptin pathways on murine obesity
46. Neuropeptides and obesity
47. Targeted deletion of the tub mouse obesity gene reveals that tubby is a loss-of-function mutation
48. Hepatic scavenger receptor BI promotes rapid clearance of high density lipoprotein free cholesterol and its transport into bile
49. Impaired biliary lipid secretion in obese Zucker rats: Leptin promotes hepatic cholesterol clearance
50. Epidemiology and natural history of gallstone disease
51. The influence of genetic background on the expression of the obese (ob) gene in the mouse
52. Metabolic complications of obesity
53. Impact of body weight and weight loss on cardiovascular risk factors
54. Insulin and gallstones
55. In vitro effects of cholecystokinin fragments on human gallbladders. Evidence for an altered CCK-receptor structure in a subgroup of patients with gallstones
56. Gene structure of human cholecystokinin (CCK) type-A receptor: Body fat content is related to CCK type-A receptor gene promoter polymorphism
57. Clustering of metabolic abnormalities in obese individuals: The role of genetic factors
58. Gallbladder motor function in obesity
59. Genetic determinants of variation in gallbladder disease in the Mexican-American population